Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Current Leases (2019 - 2025)

Historic Current Leases for Ocular Therapeutix (OCUL) over the last 7 years, with Q4 2025 value amounting to $2.8 million.

  • Ocular Therapeutix's Current Leases rose 4573.2% to $2.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.8 million, marking a year-over-year increase of 4573.2%. This contributed to the annual value of $2.8 million for FY2025, which is 4573.2% up from last year.
  • Per Ocular Therapeutix's latest filing, its Current Leases stood at $2.8 million for Q4 2025, which was up 4573.2% from $2.8 million recorded in Q3 2025.
  • In the past 5 years, Ocular Therapeutix's Current Leases registered a high of $2.8 million during Q4 2025, and its lowest value of $1.4 million during Q1 2021.
  • Its 5-year average for Current Leases is $1.9 million, with a median of $1.7 million in 2023.
  • As far as peak fluctuations go, Ocular Therapeutix's Current Leases plummeted by 1518.15% in 2024, and later surged by 6086.2% in 2025.
  • Ocular Therapeutix's Current Leases (Quarter) stood at $1.6 million in 2021, then decreased by 1.54% to $1.6 million in 2022, then decreased by 0.81% to $1.6 million in 2023, then rose by 21.88% to $1.9 million in 2024, then skyrocketed by 45.73% to $2.8 million in 2025.
  • Its last three reported values are $2.8 million in Q4 2025, $2.8 million for Q3 2025, and $2.6 million during Q2 2025.